Project Grant K99AI196248
Award Date 4/1/26
Completion Date 3/31/28
Dollars Obligated $168K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, NY 10065, USA
Similar Awards
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $616,042 to the Sloan-Kettering Institute for Cancer Research on February 3, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855). This five-year project, scheduled for completion on January 31, 2031, will deliver investigator-initiated biomedical research aimed at understanding peripheral immune tolerance mechanisms. Specifically, the research will characterize...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant totaling $3.6 million to J. David Gladstone Institutes under the Allergy and Infectious Diseases Research program (CFDA 93.855) on February 6, 2026, with a completion date of January 31, 2030. The award funds research to define multi-level regulatory networks governing regulatory T cell (Treg) stability and identity in human immune cells. The project delivers scientific...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Sloan-Kettering Institute for Cancer Research a $3.52 million Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) for research on chromatin architecture regulating trained immunity in antiviral natural killer (NK) cells. The award, obligated on July 25, 2025, funds a four-year research initiative extending through June 30, 2029, investigating how...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $794,183 to the Beckman Research Institute of the City of Hope on April 8, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855). This five-year project, extending through March 31, 2031, supports investigator-initiated biomedical research into the role and regulation of methylarginine effector Tudor Domain-Containing Protein 3 (TDRD3) in T cell immunity. The...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Trustees of Columbia University in the City of New York $3.14 million under the Allergy and Infectious Diseases Research program (CFDA 93.855) on February 6, 2026, for a project period extending through January 31, 2030. This Project Grant funds investigator-initiated biomedical research examining regulatory T cell (Treg) memory in human tissues, with the goal of advancing understanding of...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $464,750 to Icahn School of Medicine at Mount Sinai on July 7, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) for a two-year project completion period extending through June 30, 2027. The award supports research focused on understanding and modulating T cell plasticity, specifically the transdifferentiation of TH17 cells into regulatory T cells...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $3.52 million Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Sloan-Kettering Institute for Cancer Research, effective March 1, 2026, through February 28, 2030. This award supports the development of computational and clinical tools to prevent gut-borne bloodstream infections in immunocompromised patients by leveraging microbiome ecology...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $566,875 to the La Jolla Institute for Immunology under the Allergy and Infectious Diseases Research program (CFDA 93.855) on February 18, 2026, with a completion date of January 31, 2028. Under this Project Grant, the institute will conduct research to de-orphanize a novel G-protein coupled receptor (GPCR) expressed by tissue-resident memory T cells (TRM cells). The research objective...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Research Foundation for the State University of New York a Project Grant of $240,150 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 24, 2025, with completion scheduled for June 30, 2027. This research initiative investigates the mechanisms by which the Large Tumor-Antigen (LT) protein from polyomaviruses cooperates with the ETS1 proto-oncogene...
- Federal Project Grant Award Summary New York University School of Medicine received a $755,801 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 3, 2026, through January 31, 2031. This research grant supports a five-year investigation into the regulation of CD4+ and CD8+ T cell function by the protein CLNS1A. The project delivers foundational biomedical research...